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Over the past decade, the role of the microbiome in regulating metabolism, immune function and
behavior in humans has become apparent. It has become clear that the placenta is not a sterile organ, but
rather has its own endogenous microbiome. The composition of the placental microbiome is distinct
from that of the vagina and has been reported to resemble the oral microbiome. Compared to the gut
microbiome, the placental microbiome exhibits limited microbial diversity. This review will focus on the
current understanding of the placental microbiota in normal healthy pregnancy and also in disease states
including preterm birth, chorioamnionitis and maternal conditions such as obesity, gestational diabetes
mellitus and preeclampsia. Factors known to alter the composition of the placental microbiota will be
discussed in the ﬁnal part of this review.
© 2016 Published by Elsevier Ltd.Contents
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Over the past decade, the role of the microbiome (i.e. the
composite of microorganisms and its genomes on the body) in
regulating metabolism, immune function and behavior inhe placental microbiome, Placenta (2016), http://dx.doi.org/10.1016/
E. Pelzer et al. / Placenta xxx (2016) 1e82humans has become apparent. The main focus of attention has
been on the microbiota (i.e. the microorganisms present on a
certain body site) of the gastrointestinal tract but microbiota are
also present in the oral cavity, the skin, the lungs, the genito-
urinary tract and in pregnancy also in the placenta and the am-
niotic ﬂuid.
The composition of the microbiome is dependent on body site,
host-dependent factors including genetic make-up [1], dietary
intake [2], disease state [3] as well geographic location [4] and
bacterial species present [5]. For the gut microbiota, there is wide
inter- and intra-individual diversity; however, a healthy gut
microbiota in adults is mainly comprised of bacteria belonging to
the phyla Firmicutes and Bacteroidetes. An imbalance in the
composition of the microbiota is known as dysbiosis. Dysbiosis of
the gut microbiota is associated with diverse disease states
including inﬂammatory bowel disease, diabetes and asthma but
also with obesity.
In pregnancy, the gut microbiota is altered with the progression
of the pregnancy [6]. In the ﬁrst trimester of pregnancy, the gut
microbiota resembles that of outside pregnancy. At the start of the
second trimester, abundance of speciﬁc bacterial genera have been
associated with physiological parameters in the mother: abun-
dance of Collinsella is positively correlated with insulin levels [7]
whereas abundance of Odoribacter is negatively correlated with
blood pressure [8]. In the third trimester of pregnancy, the intra-
individual diversity decreases with a higher abundance of bacte-
ria belonging to the pro-inﬂammatory Proteobacteria phylum [6].
However, the inter-individual diversity increases in the third
trimester due to the loss of different species in different women.
When gut microbiota samples from women in the third trimester
were transfected into a murine model, the mice became insulin
resistant and gained weight, resembling the changes seen in
pregnant women across gestation [6]. These results suggest that in
pregnancy, the gut microbiota signiﬁcantly contribute to the
metabolic changes observed in the mother.
Until recently, the intra-uterine environment was considered
sterile except in the case of pathological infections usually associ-
ated with adverse pregnancy outcomes including preterm birth.
However, it is now clear that the placenta has its own microbiota
and that this is not necessarily associated with infections. This re-
view will focus on the current understanding of the placental
microbiota in normal pregnancy and also in disease states including
preterm birth, chorioamnionitis and maternal conditions such as
obesity, gestational diabetes mellitus and preeclampsia. Factors
known to alter the composition of the placental microbiota will be
discussed in the ﬁnal part of this review.
2. The placental microbiota in healthy pregnancy
2.1. The community composition of the placental microbiota in
healthy term pregnancies
The role of the reproductive tract microbiome in pre- and post-
conception is under current investigation [9]. Host-microbe and
microbe-microbe interactions begin before birth. These in-
teractions appear modiﬁable and are expressed as variability
within, and between individuals.
The placenta is an organ that was previously considered to be
sterile in the absence of clinical infection. However, more than
three decades ago, the presence of bacteria within placental tissue
was conﬁrmed by cultivation-dependent techniques [10]. Since
then, the presence of microorganisms within placental tissue has
been described in the presence and absence of overt infection in
cultivation-dependent and cultivation-independent (mainly PCR
and 16S rRNA sequencing) studies (Table 1) [11e17]. ComparativePlease cite this article in press as: E. Pelzer, et al., Maternal health and t
j.placenta.2016.12.003studies report that cultivation-dependent studies likely signiﬁ-
cantly underestimate the incidence of microbial presence within
the placenta, which is likely due to the presence of bacteria that
are hard to culture due to their preference for anaerobic envi-
ronments or requirement for speciﬁc unidentiﬁed nutrients
[15,16,18e20].
More recent DNA-based studies provide evidence for the pres-
ence of a low biomass endogenous microbial community within
the placenta [21]. The microbiota of placentae from healthy term
deliveries have a high abundance of Lactobacillus sp., Propioni-
bacterium spp. and members of the Enterobacteriaceae family
[13,22,23]. Lactobacilli sp. are less abundant in placental tissues of
preterm deliveries, possibly supporting a role for this genera in
positive pregnancy outcomes [16].2.2. Seeding of the placental microbiota: how do microorganisms
and their products passage into the placenta?
It is still not entirely clear how microorganisms enter the
placental fetal compartment. The current hypotheses is that
microorganisms ascend from the vagina, maternal dendritic
cells sample bacteria from the intestinal lumen which are
internalized and transported to the placenta or enter via the
blood supply to seed the microbiota of the placenta (Fig. 1)
[24]. The evidence for vaginally-derived bacteria is strong and
Lactobacillus-dominant microbiota, resembling the Lactobacilli
sp. present in the vagina, are positively correlated with gesta-
tional age [21,25e27]. Bacterial translocation via dissemination
through the blood supply is enhanced during pregnancy and
lactation. Gaps in the epithelium in for example the intestinal
and the oral mucosa enable the transfer of low numbers of
bacteria into the circulation that can then seed the placenta
[28]. The oral microbiota has recently been implicated as a
primary source of placental bacteria; however, data compari-
sons were performed against oral microbiota data from an
unrelated, non-pregnant population [21]. Animal studies have
also demonstrated transmission of oral bacteria to the placenta
[29,30], providing additional support for the seeding of the
placenta microbiome from the oral cavity.3. Other pregnancy microbiomes
Characterization of the vaginal microbiota using cultivation-
independent techniques demonstrates signiﬁcant individual vari-
ability [31]. Notably, the vaginal microbiota appears to become
more stable as gestation progresses, with less intra-individual
variability [13,32,33]. Further, the vaginal microbiota demon-
strates enrichment of members of the orders Lactobacilliales, Clos-
tridiales, Bacteroidales and Actinomycetales [34]. This further
supports a role for speciﬁc members of the microbial community in
the prevention of preterm delivery [35,36].
The placenta is established within the uterus during early
normal development. The non-pregnant, non-sterile uterus also
harbors an abundance of DNA from the genera Lactobacillus, Bac-
teroides Gardnerella and Prevotella [37e40]. In comparison,
cultivation-dependent studies identiﬁed Gardnerella, Lactobacillus
spp. and Streptococcus spp. as the most abundant isolates in the
absence of infection, and Lactobacilli, Garderella, anaerobic Gram-
negative bacilli and anaerobic Gram-positive cocci in the pres-
ence of chronic inﬂammation [37,41]. An absence of correlation
between the uterine microbiota and that of the vagina of the same
woman has also been reported, highlighting niche-speciﬁc tro-
pisms [37,39]. The microbiota of the pregnant uterus remains to be
well characterized.he placental microbiome, Placenta (2016), http://dx.doi.org/10.1016/
Table 1
Bacteria detected in placenta.
Site of detection
Amniotic ﬂuid Placenta
membranes
Placenta
Detection method Cultivation-dependent Caprocytophaga sp.
Eikenella corrodens
Klebsiella sp.
Streptococcus intermedius
Streptococcus sanguis
Streptococcus pneumoniae
Coagulase-negative staphylococci
Prevotella spp.
Staphylococcus aureus
Staphylococcus spp.
Streptococcus agalactiae
Detected by both methods Bacteroides spp.
Candida albicans
Escherichia coli
Fusobacterium nucleatum
Gardnerella vaginalis
Mycoplasma hominis
Peptostreptococcus sp.
Streptococcus viridans
Ureaplasma urealyticum
Actinomyces spp.
Corynebacterium sp.
Escherichia coli
Fusobacterium nucleatum
Gardnerella vaginalis
Mycoplasma hominis
Peptostreptococcus sp.
Propionibacterium spp.
Ureaplasma urealyticum
Clostridium
Corynebacterium sp.
Enterococcus spp.
Lactobacillus crispatus
Propionibacterium acnes
Staphylococcus spp.
Cultivation-independent Bergeyella sp.
Campylobacter sp.
Citrobacter spp.
Clostridiales
Haemophilus inﬂuenzae
Leptotrichia amnionii
Shigella spp.
Sneathia spp.
Streptococcus agalactiae
Ureaplasma parvum
Acinetobacter
Ananomyxobacter sp.
Bacteroides spp.
Burkholderia sp.
Caprocytophaga sp.
Eikenella corrodens
Enterobacter sp.
Enterococcus spp.
Haemophilus sp.
Klebsiella sp.
Leptotrichia sp.
Porphyromonas spp.
Sneathia spp.
Streptococcus intermedius
Streptococcus pneumoniae
Streptococcus sanguis
Streptococcus viridans
Streptosproangium sp.
Veillonella sp.
Xanthromonas sp.
Acinetobacter spp.
Bacillus
Bacteroidales
Biﬁdobacterium spp.
Enterobacter spp.
Escherichia coli
Fuscobacterium spp.
Fusobacterium nucleatum
Gardnerella spp.
Haemophilus parainﬂuenzae
Lachnospiraceae
Lactococcus
Lysinibacillus
Neisseria spp.
Nitrobacter
Prevotella melaninogenica
Rhodococcus
Solibacillus
Sporosarcina
Streptococcaceae
Streptococcus agalactiae
unclassiﬁed Bacillales
Ureaplasma parvum
Ureaplasma urealyticum
Veillonellaceae
Fig. 1. Seeding of the placental microbiome.
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Interaction between the human host and her microbes is a
signiﬁcant contributor to the outcome of pregnancy [42]. The intra-
amniotic immune response is a signiﬁcant determinant of neonatal
outcome associated with preterm delivery independent of gesta-
tional age [42e44]. There is evidence for the transfer of bacteria
from the mother to the fetus, which is partially independent of thePlease cite this article in press as: E. Pelzer, et al., Maternal health and t
j.placenta.2016.12.003mode of delivery. The meconium of newborn infants delivered at
term either vaginally or by Caesarean section contains commensal
bacteria, including lactic acid producing species [45]. This suggests
that the fetus is not sterile. Gram-positive cocci from a number of
genera have been detected in cultures of umbilical cord blood
collected from infants delivered by Caesarean section [46].
It is possible that the placental microbiota has a previously
unconsidered role in early innate immune development. Thehe placental microbiome, Placenta (2016), http://dx.doi.org/10.1016/
E. Pelzer et al. / Placenta xxx (2016) 1e84maternal microbiota drives early innate immune development, and
the placental microbiota is emerging as a source for antigenic de-
terminants. Bacterial presence per se does not initiate adverse
pregnancy outcomes, which further supports a positive role of
placental microbe interaction with the mother and fetus [47]. In
concordance with infectious disease studies, bacteria do not need
to be viable to elicit an immune response. A recent murine study
demonstrated the efﬁcacy of host immune priming via microbial
molecular transfer, in the absence of living bacteria [48]. This
concept further supports the signiﬁcance of identifying a low-
biomass microbiota in the placenta. Animal studies support a role
for neonatal immune priming and development in the absence of
direct microbial exposure [48].
4. The placental microbiota and adverse pregnancy outcomes
4.1. The placental microbiota composition in pregnancies with
adverse outcomes
Microbial invasion of the amniotic cavity is associated with
signiﬁcant neonatal and maternal morbidity and mortality [49].
Cultivation-dependent and independent studies have linked
placental and amniotic ﬂuid microorganisms with miscarriage,
chorioamnionitis, preterm rupture of membranes, preterm delivery
and stillbirth [21,50]. However, many of the ‘causal’ microorgan-
isms and their DNA have also been detected in the placenta and
amniotic ﬂuid of women delivering at term and in the presence and
absence of active labor [21,47,51]. Since gestational age is correlated
with speciﬁc microbial species, it suggests that just as the placenta
develops throughout gestation in response to environmental cues,
so possibly does the placental microbiota [52]. It remains unclear
whether alterations in the placental microbial communities
observed in preterm delivery are a feature of gestational age, or
whether they represent speciﬁc placental and fetal functional
physiological stages [12].
Evidence from the literature indicates that infectious bacteria
ascend from the vagina, and that perturbations of the vaginal
microbiota, as occurs in bacterial vaginosis, are associated with
adverse pregnancy outcomes [38,53]. Cultivation-dependent
studies identiﬁed members of the genera Prevotella, Bacteroides,
Peptostreptococcus, Gardnerella, Mobiluncus and genital myco-
plasmas in the placentae of women delivering preterm with or
without pre-eclampsia [15,16,19,20,54e57]. DNA-based in-
vestigations of the placental microbiota in preterm birth report
increased enrichment of Burkholderia sp. and an increased relative
abundance of Alphaprotoebacteria and Actinomycetales and mixed
non-cultivable anaerobes [20,21].
Women who deliver preterm with placental evidence of severe
chorioamnionitis also demonstrate reduced species diversity
within the placental membranes [13]. Chorioamnionitis is associ-
ated with a higher abundance of Streptococcus agalactiae, Fuso-
bacterium nucleatum andUreaplasma parvum [13,15,16,18,20]. High-
grade inﬂammation of the chorionic plate is more frequently
associated with speciﬁc species including Prevotella bivia, Coryne-
bacterium sp., Escherichia coli, Peptostreptococcus magnus, Strepto-
coccus sp. and the genital mycoplasmas [58]. Polymicrobial
infections are a hallmark of chorioamnionitis but it is not entirely
clear yet what causes the inﬁltration by bacteria causing inﬂam-
mation in the placenta [58].
4.2. Where do placental microorganisms and microbial products in
placental pathology arise?
The proposed routes of microbial access to the placenta and
amniotic cavity in adverse pregnancy outcomes are the same asPlease cite this article in press as: E. Pelzer, et al., Maternal health and t
j.placenta.2016.12.003those reported for healthy pregnancies. The genital mycoplasmas
and Streptococcus agalactiae are frequently isolated bacteria in
cases of preterm pre-labor rupture of membranes [59]. However,
bacteria isolated from the amniotic cavity are not always recovered
from the vagina suggesting an alternate route for microbial trans-
location [40]. Further, in vitro studies suggest that intact mem-
branes offer a physical barrier to some pathogenic bacteria [60].
Studies assessing the relationship between periodontal disease
and preterm birth have produced conﬂicting results [21,61]. How-
ever, fastidious bacteria including Fusobacterum nucelatum of
apparently oral cavity origin have been isolated in cases of stillbirth
[62].
Interestingly, alterations to the gastrointestinal microbiota, but
not the vaginal microbiota have been associated with women who
deliver preterm [63]. Speciﬁcally, decreased abundance of the
genera Clostridium and Bacteroides as measured in stool samples,
are known to result in impaired homeostasis [64]. There is evidence
for self-modulation between the endogenous microbiota and
pathogenic bacteria across multiple anatomical niches. The
gastrointestinal and vaginal microbiomes interact due to anatom-
ical location. For example, primary Group B Streptococcus (GBS)
carriage is rectal in origin. However, the lactic-acid producing
Lactobacilli in the vagina modulate vaginal carriage of GBS [65].
Interestingly, the majority of vaginal lactic acid cannot be produced
by human metabolism, highlighting the critical role of the endog-
enous Lactobacilli in maintaining and modulating homeostasis in
the female reproductive tract [66]. Disease previously thought
related to the presence of bacteria within the placenta and/or
amniotic cavity may actually be the result of dysbiosis in the
endogenous microbial community and a resultant loss of protective
and homeostatic modulation.
Pathogenic microorganisms in the reproductive tract during
pregnancy demonstrate tissue preferences related to adverse
pregnancy outcomes. Ureaplasmas and Gardnerella sp. are
frequently isolated from the chorioamniotic membranes, whilst
Mycoplasma, Leptotrichia, Sneathia and Bergeyella are isolated more
frequently from amniotic ﬂuid [18,20,67]. Urinary tract infections
during pregnancy have also been associated with microbial alter-
ations resulting in placental enrichment of the genera Strepto-
coccus, Arthrobacter, Klebsiella and Acinetobacter [21]. These genera
are frequently encountered in cases of intra-amniotic infection and
could potentially colonize the placenta as well.
Furthermore, microbial products including bacterial DNA, which
do not necessarily reﬂect live bacteria, appear sufﬁcient to initiate
adverse outcomes in pregnancy. Detection of bacterial DNA from
species isolated from the oral cavity has been associated with
miscarriage, preterm rupture of membranes, preterm birth, and
intrauterine fetal death for the genera Fusobacterium and Strepto-
coccus [62,68].
4.3. How does the placental microbiota precipitate adverse
pregnancy outcomes?
The contribution of the placental microbiota in adverse preg-
nancy outcomes remains to be fully elucidated; however, the pro-
duction of proinﬂammatory mediators is a signiﬁcant mechanism
in precipitating preterm birth [69]. Inﬂammation associated with
microbial presence within placental tissue is very likely associated
with species-speciﬁc virulence factors and host genetics that
modulate the host immune response and microbial tissue invasion
[55,56,70,71]. Ultimately, variability between host-microbe and
microbe-microbe interactions will determine the outcome of mi-
crobial presence at this anatomical niche.
The inﬂammatory response in cases of placental infection
frequently travels from the maternal to the fetal tissues with thehe placental microbiome, Placenta (2016), http://dx.doi.org/10.1016/
E. Pelzer et al. / Placenta xxx (2016) 1e8 5maternal immune response detectable prior to the fetal immune
response. However, in some cases the fetal response precedes the
maternal response, suggesting that the fetal tissue may be the
primary site of microbial inﬁltration [58]. This is further supported
by studies reporting dissemination of microbes from distant sites to
the placenta and amniotic cavity via the blood supply [72,73].
Cultivation-dependent and independent studies consistently
report microbial species present in both healthy term deliveries
and pregnancies impacted by adverse outcomes including miscar-
riage, chorioamnionitis, preterm birth and stillbirth. In addition,
there are no clear studies consistently implicating a single species
in adverse pregnancy outcomes. Further, in cultivation-dependent
studies, microbes were not recovered from a proportion of
placentae with high-grade inﬂammation, perhaps highlighting the
limitations of cultivation-dependent studies. All bacteria are not
created equal, and there exists signiﬁcant discordance between
cultivation-dependent bacterial identiﬁcation and clinical preg-
nancy outcomes [74]. It will be interesting to determine whether
this gap is bridged as cultivation-independent techniques become
morewidely utilized in routine diagnostics [37e40]. Finally, clinical
management of infection-related pregnancy morbidity may beneﬁt
from knowledge gained as a result of cultivation-independent
studies. For example, antibiotic treatment of women diagnosed
with BV in early pregnancy, clears the infection but does not reduce
the risk of delivering preterm [53]. Signiﬁcantly, antibiotic treat-
ment of women who test negative for BV has been associated with
preterm delivery [75]. Understanding the impact of treatment on
non-cultivable isolates may improve outcomes in time.
5. Factors changing the placental microbiota
5.1. Maternal obesity
Adverse effects of maternal obesity or excess gestational weight
gain have been linked to inﬂammation in the placenta [76] and
anomalies in feto-placental functions [77,78]. While mechanisms
are uncertain, new evidence points to the placenta microbiota. In
pregnancy, maternal obesity further modiﬁes or ampliﬁes the
changes observed in the gut microbiota. These alterations have
been shown to affect the development milieu of the offspring [79].
It is unclear if the same phenomenon occurs in the placenta. A
recent study [17] evaluated whether obesity or excess gestational
weight gain was associated with an altered placental microbiota
and if this was more pronounced among women who delivered
preterm. At phylum level, prepregnancy obesity and gestational
weight gain were not associated with signiﬁcant differences in the
placental microbiota. However, in women with premature de-
liveries, the placental microbiotawas signiﬁcantly altered by excess
gestational weight gain but not by prepregnancy obesity. An
increased abundance of Firmicutes, Actinobacteria and decreased
Proteobacteria abundance was reported. These results suggest that
aberrations in the preterm placental microbiota may be associated
with preterm birth. In addition, metagenomic analyses revealed
that the placental microbiota in women with preterm birth and
excess gestational weight gain had lower expression of genes
encoding folate biosynthesis, butanoate metabolism and increased
expression of siderophore biosynthesis. These results are tanta-
lizing but do not prove causality.
The origin of the bacteria in the placental microbiota in healthy
and unhealthy pregnancies is not fully explored. Three main routes
have been proposed: the oral-fetoplacental, gastrointestinal-feto-
placental and the genitourinary-fetoplacental (Fig. 1) [80]. Outside
pregnancy, obesity was associated with dental caries [81], imbal-
anced oral microﬂora [82], differences in cervical microﬂora [83]
and profound changes in the gut microbiota [84e87]. Therefore itPlease cite this article in press as: E. Pelzer, et al., Maternal health and t
j.placenta.2016.12.003can be hypothesized that maternal obesity and/or excess gesta-
tional weight gain may lead to dysbiosis in the placental micro-
biota. However this needs to be conﬁrmed.
5.2. Gestational diabetes mellitus (GDM)
GDM is deﬁned as ‘any degree of glucose intolerance with onset
or ﬁrst recognition during pregnancy’ [88] and is associated with
multiple adverse maternal and infant outcomes. It has been hy-
pothesized that differences in the placental microbiota could be
associated with pregnancy complications (Fig. 2) [57,89] but there
is no deﬁnitive evidence supporting this hypothesis yet. To date,
there is only one study investigating the effect of GDM on the
placental microbiota [90], which showed that the placental
microbiota fromwomenwith diagnosed GDM differed from that of
normoglycemic women. GDM women exhibited decreased abun-
dance of the order Pseudomonadales and the genus Acinetobacter.
Decreased abundance of Acinetobacter is associated with lower
blood eosinophil counts and lower placental expression of
numerous anti-inﬂammatory genes including interleukin (IL)-10.
Thus Acinetobacter may have a modulatory effect of the maternal
immune system, producing an anti-inﬂammatory milieu in the
placenta. However, no causal relationship can however be inferred
from this study due to the cross-sectional design of the study.
Maternal exposure to Acinetobacter lwofﬁi in a murine model
altered placental Toll-like receptor gene expression and lowered
the risk of asthma in the offspring. This provides additional evi-
dence for a potential anti-inﬂammatory role of this genus in the
placenta.
5.3. Probiotics and antibiotics
Human-microbial interaction may occur before birth. In mice, a
labeled strain of Enterococcus faecium can cross the placenta into
the umbilical cord [46]. In humans, the placenta and meconium of
infants have been reported to share some phylotypes [91,92].
Therefore, any microbial supplementation or bacterial suppression
during pregnancy may alter the maternal microbiome. Probiotics
and antibiotics could potentially alter the composition of the
placental microbiota but this has not yet been studied directly.
Probiotic interventions have been extensively investigated in rela-
tion to systemic inﬂammation. Maternal oral probiotic supple-
mentation can modulate TRL-related gene expression in the
placenta and fetal gut [93]. This means that modulation of the
maternal microbiome by probiotics may have an important effect
on neonatal intestinal gene expression of immune markers.
Moreover, probiotic strains belonging to Biﬁdobacterium and
Lactobacillus have been detected in human placenta [94]. Therefore
it has been hypothesized that oral probiotics before and during
pregnancy could be an alternative therapy to prevent metabolic
diseases in pregnant women at risk [90]. The effect of prebiotic
supplementation on the placental microbiota is unknown. Prebiotic
foods support beneﬁcial commensals residing in the gut microbiota
[95], however whether these effects would extend to the placental
microbiota is unclear.
Many pregnant women are exposed to antibiotics during preg-
nancy or at delivery [96]. Antibiotics cause signiﬁcant shifts in the
gut microbiota resulting in the suppression of both beneﬁcial and
pathogenic bacteria [97]. The cause and effect relationship between
antibiotic intake and the placental microbiota has not been estab-
lished. In the largest placental microbiota study to date [21], it was
not possible to elucidate whether the placental microbiota was
affected by the remote antenatal infection or by antibiotic therapy.
Of note, it has been reported that at least 11 types of broad-
spectrum antibiotics cross the placenta and reach the fetus [92].he placental microbiome, Placenta (2016), http://dx.doi.org/10.1016/
Fig. 2. Factors changing the composition of the placental microbiome.
E. Pelzer et al. / Placenta xxx (2016) 1e86This could potentially alter the ﬁrst fetal-microbial interactions,
which may inﬂuence the development of the infant microbiome.
Administration of prebiotics/probiotics to pregnant women during
pregnancy or labor may help to restore or improve the dysbiotic
maternal microbiome.
6. Conclusions
It is clear that the placenta has its own microbiota and its
composition is likely to affect pregnancy outcomes. However, since
this is a relatively novel area of research, the mechanisms by which
this occurs are still unclear. Furthermore, if and how maternal
factors including prepregnancy BMI, pre-existing disease as well as
pregnancy complications affect the placental microbiota, or the
converse, will need to be explored in future studies. A better un-
derstanding of the placental microbiota and its role in pregnancy
outcomes may contribute to the identiﬁcation of new therapeutic
targets to improve pregnancy outcomes.
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